Health

Maternity and Baby Brand Momcozy Launches 'Parachute Care Program' to Support Breastfeeding Journeys

NEW YORK, March 1, 2023 /PRNewswire/ -- Momcozy, the renowned maternity and baby brand endorsed by over 2 million moms globally, has announced the year-long Parachute Care Program  to support more moms' breastfeeding journeys. The brand has kicked off the first ...

2023-03-01 21:00 1829

GenFleet receives EMA approval for phase Ib/II study of GFH925 (KRAS G12C inhibitor) in combination with ERBITUX® (cetuximab) treating patients with advanced NSCLC in first-line setting

SHANGHAI, March 1, 2023 /PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced today that European Medicine Agency (EMA) approved the phase Ib/II study of GFH925 (KRASG12C inhibitor) in combination wit...

2023-03-01 19:00 1908

Cambrex Recognized with CDMO Leadership Awards for 9th Consecutive Year

EAST RUTHERFORD, N.J., March 1, 2023 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), announced today that it has been recognized with 2023 CDMO Leadership Awards in the categories of Quality, Service, Expertise, and Compatibility. Additionally...

2023-03-01 19:00 2307

Digital Transformation Across Life Sciences Industry Boosts Instrumentation Market

Automation and robotization to ensure industrywide streamlining and increase future growth potential SAN ANTONIO, March 1, 2023 /PRNewswire/ -- The development of next-generation sequencing (NGS) technology, a wide array of informatics, and robotics are some of the most recent technological adva...

2023-03-01 16:12 1951

FAT HOPE SHOU BE IT (FAT HOPE) Official Opens at Bugis Junction

Fat Hope Brings Korean Express Slimming Services to Singapore SINGAPORE, March 1, 2023 /PRNewswire/ -- FAT HOPE – SHOU BE IT (FAT HOPE) is proud to announce the official opening of its physical shop located at #03-05B, Bugis Junction, delivering the ultimate slimming experience to all clients. Th...

2023-03-01 15:48 2205

EW Nutrition showcases customer-focused solutions for the animal nutrition industry at VIV Asia 2023

SINGAPORE, March 1, 2023 /PRNewswire/ -- EW Nutrition will participate in VIV Asia 2023 to showcase its newest solutions for the animal nutrition industry. "We are constantly innovating to provide best-in-class products and programs. Our participation in VIV Asia 2023 is a good opportunity to con...

2023-03-01 14:10 2167

A promising picture for multi-cancer early detection in Southeast Asia - latest update from biotech firm Gene Solutions

HO CHI MINH CITY, Vietnam, March 1, 2023 /PRNewswire/ -- In January 2023, Vietnam's Medical Genetics Institute & Gene Solutions  published their research paper on Cancer Investigation:Clinical validation of a ctDNA-based assay for multi-cancer detection: an interim re...

2023-03-01 09:30 2501

AMPLIFY HEALTH ASIA PTE LIMITED APPOINTS DR AXEL BAUR AS CHIEF EXECUTIVE OFFICER

* Dr Axel Baur succeeds Dr Jonathan Broomberg as Chief Executive Officer in planned succession as Amplify Health Asia Pte Limited accelerates its commercial strategy inAsia Pacific * Dr Broomberg will reassume his role as CEO of Vitality Health International and Global Head of Health Insuranc...

2023-03-01 09:00 2399

Sinclair launches Lanluma to battle cellulite and provide buttock reshaping

SINGAPORE, March 1, 2023 /PRNewswire/ -- Global aesthetics brand Sinclair introduced its latest addition, a collagen-stimulating injectable Lanluma at the Cellulite and Buttock Reshaping: My Experience with Lanluma®, Collagen Stimulating Injectable dinner talk on February 25. The event, attended b...

2023-03-01 08:00 1928

First in Class, Mabwell Announces the TGA Approval of 9MW3811 for IND

SHANGHAI, Feb. 28, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with the layout of whole industry chain, announced that its IND application of its self-developed 9MW3811 injection for tumor and pulmonary fibrosis has been approved by the Therapeutic Goods Admi...

2023-02-28 23:00 1773

IMG Named a Best Travel Insurance Company of 2023 by Forbes Advisor

INDIANAPOLIS, Feb. 28, 2023 /PRNewswire/ -- International Medical Group® (IMG® ), an award-winning global insurance benefits and assistance services company, has been recognized for the second year in a row in the Forbes Advisor Best Of 2023 Awards category: Best Travel Insurance Companies Of 2023...

2023-02-28 22:00 1950

Global Cold Chain Transport Track & Trace Revenues in Pharma to Reach US$2.9 billion by 2027

For pharmaceutical companies to ensure product integrity and maintain regulatory compliance, deeper product monitoring, enhanced cold chain infrastructure, and focused automation will be critical NEW YORK, Feb. 28, 2023 /PRNewswire/ -- The global pharmaceutical (pharma) industry will surpassUS$1...

2023-02-28 21:30 1800

Oricell Closes $45M Series B1 Financing to Expand Development of Key Products

SHANGHAI, Feb. 28, 2023 /PRNewswire/ -- Oricell Therapeutics Co., Ltd ("Oricell" or "the Company"), aChina-based innovative pharmaceutical company committed to the development of tumor cellular immunotherapeutics, today announced the close of a$45M Series B1 investment round after the completion ...

2023-02-28 21:00 2532

Gracell Biotechnologies to Participate in Oppenheimer 33rd Annual Healthcare Conference

SAN DIEGO Calif., and SUZHOU and SHANGHAI, China, Feb. 28, 2023 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell" or the "Company"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of...

2023-02-28 21:00 1846

JW Therapeutics Announces Initiation of Clinical Study of JWATM214 in Patients with Advanced Hepatocellular Carcinoma

SHANGHAI, Feb. 28, 2023 /PRNewswire/ -- JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, announced the initiation of clinical study of JWATM214 in patients with advanced hepato...

2023-02-28 17:30 2593

Chula's AICute - An Assessment Tool for Ischemic Stroke Risk

A research team from the Faculty of Medicine and Faculty of Engineering, Chulalongkorn University has jointly developed AICute, an innovative program to assess the chance of stroke caused by heart disease (Ischemic Stroke), aimed at helping hospitals that lack cardiologists to enhance the effecti...

2023-02-28 12:24 2412

Pulnovo Medical Reports Positive One-year Results for PADN-CFDA Trial in Pulmonary Arterial Hypertension (PAH) Treatment

SHANGHAI, Feb. 28, 2023 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized OTM platform, announced positive one-year results from the Pulmonary Artery Denervation (PADN)-CFDA pivotal study at the industry's most leading American Cardiovascular Research Technologies conference (CRT 202...

2023-02-28 10:19 1764

On Rare Disease Day 2023 RemeGen Highlights Its Social Responsibility and Rare Disease Advocacy

YANTAI, China, Feb. 28, 2023 /PRNewswire/ -- RemeGen Co., Ltd.  ("RemeGen" or "the Company") (9995.HK, SHA: 688331), a commercial-stage biotechnology company, continues to strengthen its social responsibility and rare disease advocacy in unison with Rare Disease Day 2023'...

2023-02-28 09:16 2692

Over 90% of adults above the age of 50 carry the virus that causes shingles; yet only 3% of Singaporeans in this age group believe they are at high risk of developing the disease

GSK holds Shingles Awareness Week to educate Singaporeans about shingles and the importance of protection against it SINGAPORE, Feb. 28, 2023 /PRNewswire/ -- A GSK-sponsored Ipsos-MORI survey revealed only 3% of Singaporeans aged 50-79 years believe they are at high risk of developing shingles i...

2023-02-28 09:00 1867

GC Biopharma Signs Agreement with Catalyst Biosciences for the Acquisition of Rare Disease Pipeline in Hematology

* Entered into an acquisition deal of 3 programs YONGIN, South Korea, Feb. 27, 2023 /PRNewswire/ -- GC Biopharma Corp. (006280.KS), a leading provider of biopharmaceutical products inSouth Korea, announced today that it has signed an Asset Purchase Agreement with Catalyst Biosciences (NASDAQ : ...

2023-02-28 08:53 2172
1 ... 262263264265266267268 ... 848